We are live on ! Find out more
RFA

Reilly Financial Advisors Portfolio holdings

AUM $1.35B
1-Year Est. Return 22.65%
This Fund
S&P 500
This Quarter Est. Return
-12.3%
1 Year Est. Return
+22.65%
3 Year Est. Return
+99%
5 Year Est. Return
+129.17%
10 Year Est. Return
AUM
$686M
AUM Growth
-$68M
Cap. Flow
+$32.4M
Cap. Flow %
4.72%
Top 10 Hldgs %
22.16%
Holding
1,088
New
65
Increased
201
Reduced
162
Closed
120

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$11.2M
2
PANW icon
Palo Alto Networks
PANW
+$10.4M
3
ELV icon
Elevance Health
ELV
+$9.59M
4
BAC icon
Bank of America
BAC
+$8.68M
5
VLO icon
Valero Energy
VLO
+$7.47M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$12.7M
2
GS icon
Goldman Sachs
GS
+$8.54M
3
ACM icon
Aecom
ACM
+$7.59M
4
AMAT icon
Applied Materials
AMAT
+$6.79M
5
SLB icon
SLB Ltd
SLB
+$6.21M

Sector Composition

Rank Sector Weight
1 Technology 16.98%
2 Healthcare 14.31%
3 Financials 13.81%
4 Industrials 6.89%
5 Consumer Discretionary 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCX icon
851
Freeport-McMoran
FCX
$96.7B
$2K ﹤0.01%
240
-4,100
-94% -$47.8K
GLMD icon
852
Galmed Pharmaceuticals
GLMD
$4.75M
$2K ﹤0.01%
1
GTE icon
853
Gran Tierra Energy
GTE
$242M
$2K ﹤0.01%
70
HLT icon
854
Hilton Worldwide
HLT
$70.2B
$2K ﹤0.01%
33
IEFA icon
855
iShares Core MSCI EAFE ETF
IEFA
$194B
$2K ﹤0.01%
34
IWC icon
856
iShares Micro-Cap ETF
IWC
$1.51B
$2K ﹤0.01%
28
KR icon
857
Kroger
KR
$35.4B
$2K ﹤0.01%
80
-1,733
-96% -$50.3K
LCTX icon
858
Lineage Cell Therapeutics
LCTX
$279M
$2K ﹤0.01%
2,000
-286
-13% -$438
MRVL icon
859
Marvell Technology
MRVL
$196B
$2K ﹤0.01%
150
NBR icon
860
Nabors Industries
NBR
$1.24B
$2K ﹤0.01%
20
NDSN icon
861
Nordson
NDSN
$17.3B
$2K ﹤0.01%
17
RES icon
862
RPC Inc
RES
$1.31B
$2K ﹤0.01%
200
RIOT icon
863
Riot Platforms
RIOT
$8.15B
$2K ﹤0.01%
1,000
SAN icon
864
Banco Santander
SAN
$207B
$2K ﹤0.01%
518
+5
+1% +$23
SCHH icon
865
Schwab US REIT ETF
SCHH
$11.4B
$2K ﹤0.01%
98
+18
+23% +$368
SIRI icon
866
SiriusXM
SIRI
$10.4B
$2K ﹤0.01%
30
SQNS
867
Sequans Communications SA
SQNS
$40.6M
$2K ﹤0.01%
30
TEF
868
DELISTED
Telefonica
TEF
$2K ﹤0.01%
287
UIS icon
869
Unisys
UIS
$218M
$2K ﹤0.01%
200
UNFI icon
870
United Natural Foods
UNFI
$2.94B
$2K ﹤0.01%
143
VCIT icon
871
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.4B
$2K ﹤0.01%
21
-69
-77% -$5.69K
VMC icon
872
Vulcan Materials
VMC
$36.9B
$2K ﹤0.01%
17
YINN icon
873
Direxion Daily FTSE China Bull 3X ETF
YINN
$754M
$2K ﹤0.01%
+5
New +$1.94K
LSXMK
874
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$2K ﹤0.01%
80
IMGN
875
DELISTED
Immunogen Inc
IMGN
$2K ﹤0.01%
315

Similar funds

Reilly Financial Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Reilly Financial Advisors held 1,088 positions worth $686M, down 9% from $754M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Reilly Financial Advisors deployed $32.4M of net new capital in Q4 2018, opening 65 new positions and adding to 201 existing holdings. Its largest new stake was Palo Alto Networks: 334,902 shares worth $10.5M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $8.54M trimmed.

  • Reilly Financial Advisors's largest Q4 2018 buy was Palo Alto Networks: 334,902 shares worth $10.5M.
  • Reilly Financial Advisors added most to CVS Health in Q4 2018, an estimated $11.2M increase.
  • Reilly Financial Advisors's biggest Q4 2018 reduction was Goldman Sachs, cutting an estimated $8.54M.
  • Reilly Financial Advisors fully exited Aetna Inc in Q4 2018, selling an estimated $12.7M.
  • Reilly Financial Advisors's ten largest holdings make up 22% of its $686M portfolio in Q4 2018.
  • Reilly Financial Advisors opened 65 new positions and closed 120 in Q4 2018.
  • Reilly Financial Advisors's portfolio value fell 9% quarter-over-quarter to $686M.

Based on Reilly Financial Advisors's 13F filing for Q4 2018, filed 29 Jan 2019.